Clinical Research of H3F3AK27M in Spinal Glioma and Its Impact on TMZ Chemoradiotherapy
Clinical Research of H3F3AK27M in Spinal Glioma and Its Impact on TMZ Chemoradiotherapy
H3F3AK27M may be a feature of primary spinal cord glioma and affect the outcome and prognosis
 of TMZ chemoradiotherapy.
Inclusion Criteria:

 -  Surgical treatment and pathological confirmation of spinal glioma in our department
 and is the first case without any treatment before operation.

 Exclusion Criteria:

 -  The tumor is recurrent or has been treated before operation.